BioCryst Pharmaceuticals Inc
General ticker "BCRX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.6B
BioCryst Pharmaceuticals Inc follows the US Stock Market performance with the rate: 49.9%.
Estimated limits based on current volatility of 2.0%: low 7.47$, high 7.78$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [4.11$, 9.01$]
- 2024-12-30 to 2025-12-30 estimated range: [5.17$, 10.68$]
Financial Metrics affecting the BCRX estimates:
- Negative: Non-GAAP EPS, $ of -0.99 <= 0.10
- Negative: Operating cash flow per share per price, % of -7.78 <= 2.35
- Negative: Operating profit margin, % of -23.83 <= 1.03
- Negative: negative Net income
- Negative: Industry operating profit margin (median), % of -98.30 <= 2.14
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term BCRX quotes
Long-term BCRX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $157.17MM | $270.83MM | $331.41MM |
| Operating Expenses | $334.89MM | $419.26MM | $435.12MM |
| Operating Income | $-177.72MM | $-148.44MM | $-103.71MM |
| Non-Operating Income | $-4.09MM | $-95.95MM | $-122.52MM |
| Interest Expense | $59.29MM | $99.09MM | $108.24MM |
| R&D Expense | $208.81MM | $253.30MM | $216.57MM |
| Income(Loss) | $-181.81MM | $-244.38MM | $-226.23MM |
| Taxes | $2.25MM | $2.73MM | $0.31MM |
| Profit(Loss) | $-184.06MM | $-247.12MM | $-226.54MM |
| Stockholders Equity | $-106.99MM | $-294.60MM | $-455.53MM |
| Assets | $588.15MM | $550.00MM | $516.96MM |
| Operating Cash Flow | $-142.16MM | $-161.85MM | $-95.14MM |
| Capital expenditure | $2.38MM | $1.35MM | $2.17MM |
| Investing Cash Flow | $15.80MM | $-128.24MM | $-131.50MM |
| Financing Cash Flow | $359.67MM | $88.03MM | $32.48MM |
| Earnings Per Share* | $-1.03 | $-1.33 | $-1.18 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.